Skip to main content

Table 1 Participant demographics

From: Muscle synergies demonstrate only minimal changes after treatment in cerebral palsy

Treatment

N

GMFCS

Age

Gender

Height

Mass

  

I/II/III

y + mo

F:M

meters

kg

BTA

52

18/19/15

6 + 10

(2 + 11)

19:33

1.15

(0.16)

21.3

(8.7)

SDR

38

11/23/4

9 + 4

(2 + 0)

20:18

1.33

(0.10)

29.7

(6.2)

SEMLS

57

20/17/20

12 + 2

(3 + 1)

23:34

1.45

(0.16)

39.3

(14.8)

TD

31

–

9 + 3

(2 + 9)

17:14

1.38

(0.17)

33.8

(13.3)

  1. NOTE. Values are average (1 SD) or as otherwise indicated
  2. N Number of Participants, GMFCS Gross Motor Function Classification System, y + mo Years + Months, F Female, M Male, BTA Botulinum Toxin Type-A Injection,
  3. SDR Selective Dorsal Rhizotomy, SEMLS Single Event Multi-Level Orthopaedic Surgery, TD Typically-Developing Children